| Title |
Reference pricing in the presence of pseudo-generics
|
|---|---|
| Published in |
International Journal of Health Economics and Management, February 2015
|
| DOI | 10.1007/s10754-015-9165-1 |
| Pubmed ID | |
| Authors |
Ricardo Gonçalves, Vasco Rodrigues, Hélder Vasconcelos |
| Abstract |
This paper looks at producers of branded and generic pharmaceuticals' pricing decisions under two possible reimbursement schemes-reference pricing and fixed percentage reimbursement-and under two settings-one where the branded producer only sells the (off-patent) branded pharmaceutical and another where, in addition, it may also sell its own generic version, a so called pseudo-generic. We find different pricing responses from firms under the two reimbursement schemes and across the two settings analysed (with or without a pseudo-generic), and show that pseudo-generics may have an anticompetitive effect. Our results have important policy implications such as showing that the presence of pseudo-generics reinforces reference pricing's advantages over alternative reimbursement schemes. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Scientists | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 17 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 7 | 41% |
| Other | 1 | 6% |
| Student > Master | 1 | 6% |
| Student > Bachelor | 1 | 6% |
| Professor > Associate Professor | 1 | 6% |
| Other | 1 | 6% |
| Unknown | 5 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Economics, Econometrics and Finance | 6 | 35% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 12% |
| Nursing and Health Professions | 1 | 6% |
| Social Sciences | 1 | 6% |
| Unknown | 7 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 July 2015.
All research outputs
#14,708,028
of 23,857,313 outputs
Outputs from International Journal of Health Economics and Management
#83
of 104 outputs
Outputs of similar age
#188,833
of 358,465 outputs
Outputs of similar age from International Journal of Health Economics and Management
#1
of 1 outputs
Altmetric has tracked 23,857,313 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 104 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 358,465 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them